Evidence map›Paper›PMID 24564510›Full record

SynthesisBMC public health2013

Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus.

Jai K Das, Anjali Tripathi, Anum Ali, Amman Hassan, Chesarahima Dojosoeandy, Zulfiqar A Bhutta

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMC public health, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Systematic review of the economic value of diarrheal vaccines.Human vaccines & immunotherapeutics · 2014
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Suboptimal Bacteriological Quality of Household Water in Municipal Ibadan, Nigeria.The American journal of tropical medicine and hygiene · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jai K Das
Anjali Tripathi
Anum Ali
Amman Hassan
Chesarahima Dojosoeandy
Zulfiqar A Bhutta
Aga Khan University · PKCentre for Global Health Research · CAHospital for Sick Children · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiarrhea is a leading cause of mortality in children under 5 years along with its long-term impact on growth and cognitive development. Despite advances in the understanding of diarrheal disorders and management strategies, globally nearly 750,000 children die annually as a consequence of diarrhea.

methodsWe conducted a systematic review of the efficacy and effectiveness studies. We used a standardized abstraction and grading format and performed meta-analyses for all outcomes. The estimated effect of cholera, shigella, Enterotoxigenic Escherichia coli (ETEC) and rotavirus vaccines was determined by applying the standard Child Health Epidemiology Reference Group (CHERG) rules.

resultsA total of 24 papers were selected and analyzed for all the four vaccines. Based on the evidence, we propose a 74% mortality reduction in rotavirus specific mortality, 52% reduction in cholera incidence due to their respective vaccines. We did not find sufficient evidence and a suitable outcome to project mortality reductions for cholera, ETEC and shigella in children under 5 years.

conclusionVaccines for rotavirus and cholera have the potential to reduce diarrhea morbidity and mortality burden. But there is no substantial evidence of efficacy for ETEC and shigella vaccines, although several promising vaccine concepts are moving from the development and testing pipeline towards efficacy and Phase 3 trials.

Indexed as

Bacterial VaccinesChildChild, PreschoolCholeraCholera VaccinesComorbidityDiarrheaDysenteryDysentery, BacillaryEscherichia coli InfectionsHumansImmunization ScheduleInfantMaleRotavirus InfectionsShigella VaccinesBacterial VaccinesCholera VaccinesShigella VaccinesViral Vaccines

Identifiers

PMID24564510
PMCPMC3847224
OpenAlexW2136776738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.